Grünenthal Meds
Bhavika Patel is a seasoned professional in the field of regulatory affairs with extensive experience spanning over 18 years. Currently serving as a Senior Regulatory Affairs Officer at Glenmark Pharmaceuticals since August 2024, Bhavika has held significant roles at Kyowakirin International Newco Limited and Kyowa Kirin Co., Ltd. prior to this. Previous positions include Regulatory Affairs Officer at Glenmark Pharmaceuticals and Research Scientist at Astron Research Ltd. Bhavika began the career as an Analyst in Analytical Development Lab at Torrent Pharmaceuticals Ltd. and worked as a Research Associate at Astron Research Centre. Education includes a B.Pharm degree from North Gujarat University, completed from 2000 to 2003.
This person is not in the org chart
This person is not in any teams
Grünenthal Meds
1 followers
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.